IBDEI14D ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,18160,1,4,0)
;;=4^E11.44
;;^UTILITY(U,$J,358.3,18160,2)
;;=^5002648
;;^UTILITY(U,$J,358.3,18161,0)
;;=E11.49^^61^805^8
;;^UTILITY(U,$J,358.3,18161,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,18161,1,3,0)
;;=3^DM Type 2 w/ Diab Neurological Compl
;;^UTILITY(U,$J,358.3,18161,1,4,0)
;;=4^E11.49
;;^UTILITY(U,$J,358.3,18161,2)
;;=^5002649
;;^UTILITY(U,$J,358.3,18162,0)
;;=E11.59^^61^805^25
;;^UTILITY(U,$J,358.3,18162,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,18162,1,3,0)
;;=3^DM Type 2 w/ Oth Circulatory Compl
;;^UTILITY(U,$J,358.3,18162,1,4,0)
;;=4^E11.59
;;^UTILITY(U,$J,358.3,18162,2)
;;=^5002652
;;^UTILITY(U,$J,358.3,18163,0)
;;=E11.610^^61^805^9
;;^UTILITY(U,$J,358.3,18163,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,18163,1,3,0)
;;=3^DM Type 2 w/ Diab Neuropathic Arthropathy
;;^UTILITY(U,$J,358.3,18163,1,4,0)
;;=4^E11.610
;;^UTILITY(U,$J,358.3,18163,2)
;;=^5002653
;;^UTILITY(U,$J,358.3,18164,0)
;;=E11.618^^61^805^26
;;^UTILITY(U,$J,358.3,18164,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,18164,1,3,0)
;;=3^DM Type 2 w/ Oth Diab Arthropathy
;;^UTILITY(U,$J,358.3,18164,1,4,0)
;;=4^E11.618
;;^UTILITY(U,$J,358.3,18164,2)
;;=^5002654
;;^UTILITY(U,$J,358.3,18165,0)
;;=E11.621^^61^805^16
;;^UTILITY(U,$J,358.3,18165,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,18165,1,3,0)
;;=3^DM Type 2 w/ Foot Ulcer
;;^UTILITY(U,$J,358.3,18165,1,4,0)
;;=4^E11.621
;;^UTILITY(U,$J,358.3,18165,2)
;;=^5002656
;;^UTILITY(U,$J,358.3,18166,0)
;;=E11.622^^61^805^31
;;^UTILITY(U,$J,358.3,18166,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,18166,1,3,0)
;;=3^DM Type 2 w/ Oth Skin Ulcer
;;^UTILITY(U,$J,358.3,18166,1,4,0)
;;=4^E11.622
;;^UTILITY(U,$J,358.3,18166,2)
;;=^5002657
;;^UTILITY(U,$J,358.3,18167,0)
;;=E11.628^^61^805^30
;;^UTILITY(U,$J,358.3,18167,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,18167,1,3,0)
;;=3^DM Type 2 w/ Oth Skin Compl
;;^UTILITY(U,$J,358.3,18167,1,4,0)
;;=4^E11.628
;;^UTILITY(U,$J,358.3,18167,2)
;;=^5002658
;;^UTILITY(U,$J,358.3,18168,0)
;;=E11.630^^61^805^33
;;^UTILITY(U,$J,358.3,18168,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,18168,1,3,0)
;;=3^DM Type 2 w/ Periodontal Disease
;;^UTILITY(U,$J,358.3,18168,1,4,0)
;;=4^E11.630
;;^UTILITY(U,$J,358.3,18168,2)
;;=^5002659
;;^UTILITY(U,$J,358.3,18169,0)
;;=E11.638^^61^805^29
;;^UTILITY(U,$J,358.3,18169,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,18169,1,3,0)
;;=3^DM Type 2 w/ Oth Oral Compl
;;^UTILITY(U,$J,358.3,18169,1,4,0)
;;=4^E11.638
;;^UTILITY(U,$J,358.3,18169,2)
;;=^5002660
;;^UTILITY(U,$J,358.3,18170,0)
;;=E11.641^^61^805^20
;;^UTILITY(U,$J,358.3,18170,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,18170,1,3,0)
;;=3^DM Type 2 w/ Hypoglycemia w/ Coma
;;^UTILITY(U,$J,358.3,18170,1,4,0)
;;=4^E11.641
;;^UTILITY(U,$J,358.3,18170,2)
;;=^5002661
;;^UTILITY(U,$J,358.3,18171,0)
;;=E11.649^^61^805^21
;;^UTILITY(U,$J,358.3,18171,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,18171,1,3,0)
;;=3^DM Type 2 w/ Hypoglycemia w/o Coma
;;^UTILITY(U,$J,358.3,18171,1,4,0)
;;=4^E11.649
;;^UTILITY(U,$J,358.3,18171,2)
;;=^5002662
;;^UTILITY(U,$J,358.3,18172,0)
;;=E11.65^^61^805^17
;;^UTILITY(U,$J,358.3,18172,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,18172,1,3,0)
;;=3^DM Type 2 w/ Hyperglycemia
;;^UTILITY(U,$J,358.3,18172,1,4,0)
;;=4^E11.65
;;^UTILITY(U,$J,358.3,18172,2)
;;=^5002663
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI14D 3779 printed Sep 23, 2025@19:37:31 Page 2
IBDEI14D ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,18160,1,4,0)
+2 ;;=4^E11.44
+3 ;;^UTILITY(U,$J,358.3,18160,2)
+4 ;;=^5002648
+5 ;;^UTILITY(U,$J,358.3,18161,0)
+6 ;;=E11.49^^61^805^8
+7 ;;^UTILITY(U,$J,358.3,18161,1,0)
+8 ;;=^358.31IA^4^2
+9 ;;^UTILITY(U,$J,358.3,18161,1,3,0)
+10 ;;=3^DM Type 2 w/ Diab Neurological Compl
+11 ;;^UTILITY(U,$J,358.3,18161,1,4,0)
+12 ;;=4^E11.49
+13 ;;^UTILITY(U,$J,358.3,18161,2)
+14 ;;=^5002649
+15 ;;^UTILITY(U,$J,358.3,18162,0)
+16 ;;=E11.59^^61^805^25
+17 ;;^UTILITY(U,$J,358.3,18162,1,0)
+18 ;;=^358.31IA^4^2
+19 ;;^UTILITY(U,$J,358.3,18162,1,3,0)
+20 ;;=3^DM Type 2 w/ Oth Circulatory Compl
+21 ;;^UTILITY(U,$J,358.3,18162,1,4,0)
+22 ;;=4^E11.59
+23 ;;^UTILITY(U,$J,358.3,18162,2)
+24 ;;=^5002652
+25 ;;^UTILITY(U,$J,358.3,18163,0)
+26 ;;=E11.610^^61^805^9
+27 ;;^UTILITY(U,$J,358.3,18163,1,0)
+28 ;;=^358.31IA^4^2
+29 ;;^UTILITY(U,$J,358.3,18163,1,3,0)
+30 ;;=3^DM Type 2 w/ Diab Neuropathic Arthropathy
+31 ;;^UTILITY(U,$J,358.3,18163,1,4,0)
+32 ;;=4^E11.610
+33 ;;^UTILITY(U,$J,358.3,18163,2)
+34 ;;=^5002653
+35 ;;^UTILITY(U,$J,358.3,18164,0)
+36 ;;=E11.618^^61^805^26
+37 ;;^UTILITY(U,$J,358.3,18164,1,0)
+38 ;;=^358.31IA^4^2
+39 ;;^UTILITY(U,$J,358.3,18164,1,3,0)
+40 ;;=3^DM Type 2 w/ Oth Diab Arthropathy
+41 ;;^UTILITY(U,$J,358.3,18164,1,4,0)
+42 ;;=4^E11.618
+43 ;;^UTILITY(U,$J,358.3,18164,2)
+44 ;;=^5002654
+45 ;;^UTILITY(U,$J,358.3,18165,0)
+46 ;;=E11.621^^61^805^16
+47 ;;^UTILITY(U,$J,358.3,18165,1,0)
+48 ;;=^358.31IA^4^2
+49 ;;^UTILITY(U,$J,358.3,18165,1,3,0)
+50 ;;=3^DM Type 2 w/ Foot Ulcer
+51 ;;^UTILITY(U,$J,358.3,18165,1,4,0)
+52 ;;=4^E11.621
+53 ;;^UTILITY(U,$J,358.3,18165,2)
+54 ;;=^5002656
+55 ;;^UTILITY(U,$J,358.3,18166,0)
+56 ;;=E11.622^^61^805^31
+57 ;;^UTILITY(U,$J,358.3,18166,1,0)
+58 ;;=^358.31IA^4^2
+59 ;;^UTILITY(U,$J,358.3,18166,1,3,0)
+60 ;;=3^DM Type 2 w/ Oth Skin Ulcer
+61 ;;^UTILITY(U,$J,358.3,18166,1,4,0)
+62 ;;=4^E11.622
+63 ;;^UTILITY(U,$J,358.3,18166,2)
+64 ;;=^5002657
+65 ;;^UTILITY(U,$J,358.3,18167,0)
+66 ;;=E11.628^^61^805^30
+67 ;;^UTILITY(U,$J,358.3,18167,1,0)
+68 ;;=^358.31IA^4^2
+69 ;;^UTILITY(U,$J,358.3,18167,1,3,0)
+70 ;;=3^DM Type 2 w/ Oth Skin Compl
+71 ;;^UTILITY(U,$J,358.3,18167,1,4,0)
+72 ;;=4^E11.628
+73 ;;^UTILITY(U,$J,358.3,18167,2)
+74 ;;=^5002658
+75 ;;^UTILITY(U,$J,358.3,18168,0)
+76 ;;=E11.630^^61^805^33
+77 ;;^UTILITY(U,$J,358.3,18168,1,0)
+78 ;;=^358.31IA^4^2
+79 ;;^UTILITY(U,$J,358.3,18168,1,3,0)
+80 ;;=3^DM Type 2 w/ Periodontal Disease
+81 ;;^UTILITY(U,$J,358.3,18168,1,4,0)
+82 ;;=4^E11.630
+83 ;;^UTILITY(U,$J,358.3,18168,2)
+84 ;;=^5002659
+85 ;;^UTILITY(U,$J,358.3,18169,0)
+86 ;;=E11.638^^61^805^29
+87 ;;^UTILITY(U,$J,358.3,18169,1,0)
+88 ;;=^358.31IA^4^2
+89 ;;^UTILITY(U,$J,358.3,18169,1,3,0)
+90 ;;=3^DM Type 2 w/ Oth Oral Compl
+91 ;;^UTILITY(U,$J,358.3,18169,1,4,0)
+92 ;;=4^E11.638
+93 ;;^UTILITY(U,$J,358.3,18169,2)
+94 ;;=^5002660
+95 ;;^UTILITY(U,$J,358.3,18170,0)
+96 ;;=E11.641^^61^805^20
+97 ;;^UTILITY(U,$J,358.3,18170,1,0)
+98 ;;=^358.31IA^4^2
+99 ;;^UTILITY(U,$J,358.3,18170,1,3,0)
+100 ;;=3^DM Type 2 w/ Hypoglycemia w/ Coma
+101 ;;^UTILITY(U,$J,358.3,18170,1,4,0)
+102 ;;=4^E11.641
+103 ;;^UTILITY(U,$J,358.3,18170,2)
+104 ;;=^5002661
+105 ;;^UTILITY(U,$J,358.3,18171,0)
+106 ;;=E11.649^^61^805^21
+107 ;;^UTILITY(U,$J,358.3,18171,1,0)
+108 ;;=^358.31IA^4^2
+109 ;;^UTILITY(U,$J,358.3,18171,1,3,0)
+110 ;;=3^DM Type 2 w/ Hypoglycemia w/o Coma
+111 ;;^UTILITY(U,$J,358.3,18171,1,4,0)
+112 ;;=4^E11.649
+113 ;;^UTILITY(U,$J,358.3,18171,2)
+114 ;;=^5002662
+115 ;;^UTILITY(U,$J,358.3,18172,0)
+116 ;;=E11.65^^61^805^17
+117 ;;^UTILITY(U,$J,358.3,18172,1,0)
+118 ;;=^358.31IA^4^2
+119 ;;^UTILITY(U,$J,358.3,18172,1,3,0)
+120 ;;=3^DM Type 2 w/ Hyperglycemia
+121 ;;^UTILITY(U,$J,358.3,18172,1,4,0)
+122 ;;=4^E11.65
+123 ;;^UTILITY(U,$J,358.3,18172,2)
+124 ;;=^5002663
